American Century Companies’s ProPhase Labs PRPH Stock Holding History

American Century Companies’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,653	Closed	-$334K	–	2914
2023 Q3	$334K	Buy	7,653 +196	+3%	+$11.5K	﹤0.01%	2417
2023 Q2	$541K	Sell	7,457 -560	-7%	-$45.6K	﹤0.01%	2183
2023 Q1	$598K	Buy	8,017 +1,317	+20%	+$106K	﹤0.01%	2061
2022 Q4	$645K	Buy	6,700 +1,810	+37%	+$196K	﹤0.01%	1960
2022 Q3	$552K	Buy	+4,890	New	+$569K	﹤0.01%	1919

Other funds holding PRPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies's PRPH Position: Q4 2023 in Review

American Century Companies sold out of ProPhase Labs (PRPH) in Q4 2023, closing a stake of 7,653 shares — an estimated $334K sold.

American Century Companies first reported a position in PRPH in Q3 2022 and held it in 5 quarters. The position peaked at $645K in Q4 2022. 27 funds tracked by Wall St. Rank hold PRPH as of Q4 2023.

American Century Companies reported no remaining ProPhase Labs position as of Q4 2023 after selling out during the quarter.
American Century Companies sold 7,653 ProPhase Labs shares in Q4 2023, an estimated $334K.
American Century Companies first reported a position in ProPhase Labs in Q3 2022 and held it in 5 quarters.
American Century Companies's ProPhase Labs position peaked at $645K in Q4 2022.
27 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2023.

Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.